Neuralstem, Inc. is focused on developing and commercializing of treatments for central nervous system disease based on transplanting human neural stem cells and small molecule drugs. The Company has developed and maintain a portfolio of patents and patent applications that form the base of its research and development efforts in the areas of neural stem cell research, small molecule research, and related technologies.
04/10/11Neuralstem shares jump over 13% on new stem cell patent
16/12/10Neuralstem Receives FDA Approval to Start Phase Ia Trial for Depression Drug
14/09/10Study Shows Neuralstem’s Stem Cells May Have Application To Treating Stroke
Recent Sector News
U.S. stocks moved to end slightly higher Friday, but still recorded sharp losses for the week. Investors assessed a speech by Fed Chair Janet Yellen, who said that she expects economic conditions may warrant gradual rate hikes this year.
The cross-border partner will have an exclusive license to manufacture, market and sell specific Wildflower branded merchandise in the State of Washington. In turn, Wildflower will receive a licensing fee equal to 20 percent of the gross sales of its branded products.
The American company will be able to advance its expertise in cancer immunotherapies and biosimilars, which are two of the fastest growing sectors of the industry.
At the 12th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders being held in Nice, France, Biogen discussed the results from clinical trials of its experimental treatment Aducanumab (BIIB037).
Shares of Aldeyra Therapeutics (NASDAQ:ALDX) rose on Friday after the company's price target was lifted by analysts at H.C. Wainwright, who cited a pivotal year for clinical studies in 2015.
Retrophin's (NASDAQ:RTRX) shares were jumping premarket after the U.S. FDA approved its Cholbam capsules to treat rare bile acid synthesis disorders caused by single enzyme defects.
Investors interested in Neuralstem recently viewed
- Ergomed (AIM: ERGO) Drug development services and portfolio of co-development partnerships
- Nanobiotix (EURONEXT: NANO) .
- Enertopia Corp. (CNSX: TOP) A leading provider of medical marihuana in Canada
- Admedus (ASX: AHZ) Making a difference in Healthcare
- ImmuPharma PLC (AIM: IMM) Drug Discovery & Development to Treat Lupus, Cancer & MRSA